Targetable mutations are typically identified through genomic sequencing techniques such as next-generation sequencing (NGS). These methods can detect various genetic alterations, including point mutations, insertions, deletions, and gene fusions. Once identified, these mutations can be matched with existing targeted therapies or used to develop new drugs.
